Vectura Group (VEC)

 

VEC Share PerformanceMore

52 week high179.00 19/04/16
52 week low122.90 30/08/16
52 week change -18.80 (-11.60%)
4 week volume31,436,984 29/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Vectura achieves £9m royalty cap

Vectura Group says it has achieved the 9m calendar year royalty cap on net sales of GSK's Ellipta products in 2016. This wa...

Vectura achieves ?9 million royalty cap

RNS Number: 0193X Vectura Group plc 16 February 2017 Vectura Group plc Vectura achieves 9 million royalty cap from GSK Ellipta products Chippenham, UK, 16 February 2017: Vectura Group plc (LSE: VEC) ("the Group"), an industry-leading inhaled airways disease focused business, announces that, based on the continued strong performance of GSK's Ellipta p...

Notice of Results

RNS Number: 9372W Vectura Group plc 15 February 2017 Vectura Group plc Notice of Preliminary Results Chippenham, UK, 15 February 2017: Vectura Group plc (LSE: VEC) ("the Group"), an industry-leading inhaled airways disease focused business, plans to announce its Preliminary Results for the nine month period ended 31 December 2016 on Tuesday 21 Marc...

Director/PDMR Shareholding

RNS Number: 5310W Vectura Group plc 09 February 2017 VECTURA GROUP PLC DIRECTOR/PDMR SHARE DEALING Vectura Group plc 9 February 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them Vectura Group plc (LSE: VEC; "Vectura" or "the Company") c...

Holding(s) in Company

RNS Number: 7722V Vectura Group plc 01 February 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Vectura Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acqu...

The stockmarket in February: Three winning stocks

Shares tend to bounce back from new year weakness in February, with the FTSE All Share falling just three times since 19...

VOTING RIGHTS AND CAPITAL

RNS Number: 7281V Vectura Group plc 01 February 2017 VECTURA GROUP PLC (the "Company") VOTING RIGHTS AND CAPITAL Chippenham, UK, 1 February 2017: Vectura Group plc (LSE: VEC) notifies that the Company's issued share capital as at 31 January 2017 consisted of 677,976,017 ordinary shares (previously 677,969,321 ordinary shares as at 31 Decem...

Vectura triggers $5m milestone

Vectura Group said a sales milestone receipt of $5m has been triggered after confirmation by Novartis that EU/ROW com...

Fundamental DataMore

P/E ratio119.333
EPS1.2
Dividend yield0 %

Latest discussion posts More

  • Re: FDA approves IND on wholly owned VR6...

    Email just sent & I will advise of the response -which I would be disappointed not to receive .
    22-Feb-2017
    dave297
  • Re: FDA approves IND on wholly owned VR6...

    dave 297 Dave this post is in regard to your post of 20/01/17 ,in which you asked me , had I E -Mailed the CEO about the China project/ J.V. In answer to that question I ...
    22-Feb-2017
    d gaser
  • Re: Vectura #9m royalty cap +#...

    Tempus comment from Times this morning: "And finally . . . When Vectura bought Skyepharma last summer it was seen as a complementary merger between two middle-ranking ...
    17-Feb-2017
    SaltyDog461

Users' HoldingsMore

Users who hold Vectura Group also hold..
LLOYDS GRP.30%
VODAFONE GRP.22%
BP19%
TESCO16%
BARCLAYS16%

Codes & Symbols

ISINGB00B01D1K48
SymbolsVEC, LSE:VEC, VEC.L, VEC:LN, LON:VEC, XLON:VEC